Later on, another study from Japan revealed EGCG attenuates obesity-related hepatocarcinogenesis though suppressing the IGF/IGF-1R axis, alleviating hyperinsulinemia, and reducing chronic inflammation (Shimizu et al., 2011b). The gene discussed is IGF1; the disease is Obesity.